日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

P-435. Utility of Second Sample Testing in Indian Children Suffering from Tuberculosis with Rifampicin Indeterminate Results on Xpert MTB/Rif and Xpert Ultra Assays

P-435. 对使用利福平治疗结核病的印度儿童进行二次样本检测,若Xpert MTB/Rif和Xpert Ultra检测结果不确定,则需进行二次样本检测。

Ayala, S; Escobar, N; Vizeu Barrozo, L; Chiaravalloti-Neto, F; Canals, M; Gandhi, Dhruv; Amesur, Viren; Mehta, Vaidehi; Patil, Sonal; Mamtora, Dhruv; Shah, Ira